Abstract:The spike (S) and nucleocapsid (N) proteins, which are responsible for viral binding to cell surface receptors and the formation of ribonucleoprotein complexes during virion assembling, are major structure proteins of severe acute respiratory syndrome coronavirus (SARS-CoV). The expression of recombinant protein may give more accurate result for detecting SARS-CoV infection. A novel fusion protein,comprising of two fragments of N and S proteins from SARS-CoV, was prepared. Our computer-assisted analysis suggested that the immunodominant domains were located in the amino acid residues 1-227 of N protein and 450-650 of S protein, further the fusion of the two fragments did not change the immunochemical characteristics. The complementary DNA(cDNA) encoding N1-227 fused with S450-650 was obtained by sequence overlapping extension (SOE), and named NLS. It was cloned into pET-28a ( + ), an expression vector for His-tag fusion protein. This new constructed fusion protein was prokaryotic expressed in E. coli,and purified by metal chelate affinity chromatography with the purity over 95 %. The purified fusion protein was identified by anti-His monoclonal antibody and convalescence SARS patients serum. The NLS protein based ELISA showed that NLS maintained appropriate antigenicity and specificity to react with the sera of convalescent SARS patients. The functional NLS protein were successfully expressed and purified. And the fusion protein based ELISA can be used for detection of antibodies (Abs) against the S and N proteins of SARS-CoV. It may provided a novel diagnostic tool and have the potential application in developing of anti-SARS vaccine.

Expression, purification and sublocalization of SARS-CoV nucleocapsid protein in insect cells.

Preparation and Preliminary Application of Recombinant Severe Acute Respiratory Syndrome Coronavirus (Sars-Cov) N Protein

[Expression and Purification of Recombinant N-terminal Protein of SARS S1 Subunit Expressed in E. Coli].

Expression, Purification and Antigen Analysis of SARS-associated Coronavirus Nucleocapsid Protein in Pichia Pastoris System

Cloning, Expression, Purification of a Fusion Protein of SARS-CoV Nucleocapsid and Spike Protein Fragments and Its Immunological Characteristics

Expression and Identification of SARS-CoV Nucleocapsid Protein

Expression and purification of recombinant SARS-CoV-2 nucleocapsid protein in inclusion bodies and its application in serological detection

Efficient overexpression and purification of severe acute respiratory syndrome coronavirus 2 nucleocapsid proteins in Escherichia coli

Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus

Efficient overexpression and purification of SARS-CoV-2 Nucleocapsid proteins in

Expression of the Receptor-Binding Region of SARS-CoV Spike Protein in Baculovirus Vector and Identifying Its Antigenicity

[Expression and Purification of Recombinant SARS Coronavirus Spike Protein].

Biochemical Characterization of SARS-CoV-2 Nucleocapsid Protein

The Epitope Study on the SARS-CoV Nucleocapsid Protein

In Vitro Expression of SARS Coronavirus(sars-Cov)nucleocapsid Protein and Examination of the Function of Monoclonal Antibody Induced by the Expressed Protein

Characterization of the Heptad Repeat Regions, HR1 and HR2, and Design of a Fusion Core Structure Model of the Spike Protein from Severe Acute Respiratory Syndrome (SARS) Coronavirus.

The C-terminal portion of the nucleocapsid protein demonstrates SARS-CoV antigenicity.

The Structure Analysis and Antigenicity Study of the N Protein of SARS-CoV.

Expression and purification S protein of SARS-CoV

Nuclear/nucleolar Localization Properties of C-terminal Nucleocapsid Protein of SARS Coronavirus.

Correction: A Systemic and Molecular Study of Subcellular Localization of SARS-CoV-2 Proteins